The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park have granted Cellth Systems exclusive licensing rights for the commercial development of cell-tethering technology that allows real-time analysis of circulating tumor cells (CTCs), which has important applications in cancer treatment. In addition, Cellth announced today that TEDCO, an independent organization assisting and funding Maryland’s startup community, has awarded the company $150,000 through its Maryland Innovation Initiative (MII) program.
{iframe}http://www.umventures.org/news/cellth-systems-and-university-maryland-enter-license-agreement-advance-new-circulating-tumor{/iframe}